AVGEMSI (GEMCITABINE HYDROCHLORIDE) — FDA Approval NDA219920 (AVYXA HOLDINGS)
AVGEMSI (GEMCITABINE HYDROCHLORIDE) — FDA Approval NDA219920 (AVYXA HOLDINGS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: AVGEMSI; Active ingredients: GEMCITABINE HYDROCHLORIDE; Application number: NDA219920.
| Brand name | AVGEMSI |
|---|---|
| Active ingredients | GEMCITABINE HYDROCHLORIDE |
| Application number | NDA219920 |
| Sponsor | AVYXA HOLDINGS |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20250627 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →